Generex Biotechnology
Generex Biotechnology Corporation has been working to develop a peptide vaccine against the new coronavirus SARS-CoV-2 using the company’s proprietary and patented Ii-Key immune system activation technology.
Rankings by
National Ranking498th
in United States Regional Ranking566th
in North America and Caribbean Global Ranking1367th
worldwide